|
Volumn 15, Issue 2, 2015, Pages 594-597
|
The therapy of gefitinib towards breast cancer partially through reversing breast cancer biomarker arginine
|
Author keywords
Arginine; Breast cancer; Gefitinib; Metabolomics
|
Indexed keywords
ARGININE;
GEFITINIB;
TUMOR MARKER;
ANTINEOPLASTIC AGENT;
QUINAZOLINE DERIVATIVE;
AMINO ACID BLOOD LEVEL;
AREA UNDER THE CURVE;
ARTICLE;
BREAST CANCER;
BREAST CARCINOGENESIS;
CHINA;
CONTROLLED STUDY;
DRUG MECHANISM;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
METABOLOMICS;
PREDICTIVE VALUE;
RECEIVER OPERATING CHARACTERISTIC;
SENSITIVITY AND SPECIFICITY;
TREATMENT DURATION;
ADULT;
BLOOD;
BREAST NEOPLASMS;
CASE CONTROL STUDY;
MASS SPECTROMETRY;
METABOLISM;
PATHOLOGY;
ADULT;
ANTINEOPLASTIC AGENTS;
AREA UNDER CURVE;
ARGININE;
BREAST NEOPLASMS;
CASE-CONTROL STUDIES;
FEMALE;
HUMANS;
MASS SPECTROMETRY;
METABOLOMICS;
PREDICTIVE VALUE OF TESTS;
QUINAZOLINES;
ROC CURVE;
SENSITIVITY AND SPECIFICITY;
|
EID: 84930063365
PISSN: 16806905
EISSN: None
Source Type: Journal
DOI: 10.4314/ahs.v15i2.36 Document Type: Article |
Times cited : (13)
|
References (8)
|